Fred Hutch Receives $710 Million Gift from the Bezos Family

The donation will fund recruitment, research facilities, clinical research, and immunotherapy research.

Written byShawna Williams
| 1 min read
exterior of Fred Hutch research building
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Jeff Bezos’s family has committed to donating $710.5 million to the Fred Hutchinson Cancer Center in Seattle, the institution announced yesterday (October 12). According to the Associated Press, the gift is the largest Fred Hutch has ever received.

Earlier this year, Fred Hutch, which formerly bore the full name “Fred Hutchinson Cancer Research Center,” merged with the Seattle Cancer Care Alliance to become Fred Hutchinson Cancer Center, and also formed close ties with Seattle Children’s and the University of Washington’s UW Medicine.

“As long-time Fred Hutch supporters, we were encouraged to see the recent merger expand its capacity to aggressively investigate and treat cancer and infectious diseases,” says Mike Bezos, the stepfather of Amazon founder Jeff Bezos, in the announcement. “Science, particularly cancer and virus research, is at such a pivotal point right now. We hope our investment in the Hutch leads to answers for the most pressing medical questions.”

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies